Partially Verified65% confidenceTradeoffTime unknown
核心权衡：胃肠刺激极低、对胃溃疡及出血风险人群友好，但代价是完全不具备抗炎功效，且日剂量上限相对严格，超量伤肝
3
Sources
65%
Confidence
Long-term
Relevance
-
First Seen
Sources
Related Entities
Related Claims
Unverified核心权衡：胃肠刺激极低适合空腹或胃敏感人群服用，但代价是没有抗炎效果且镇痛强度相对布洛芬偏弱91% similarUnverified核心优势是胃肠刺激极低，适合有胃溃疡史、胃敏感或不能耐受布洛芬的人群；代价是不具备抗炎功能且止痛强度对中重度炎症痛可能不足89% similarUnverified核心优势是胃肠刺激小、可空腹服用，适合有胃炎/胃溃疡等不能使用布洛芬的人群83% similarUnverified相比纯番泻叶制剂，腹痛、腹泻等刺激性副作用发生率较低，适合对肠道刺激敏感的人群81% similarUnverified有胃溃疡、胃出血病史或胃肠道敏感者不适合，布洛芬对胃黏膜有刺激性，缓释剂型虽减轻但未消除该风险80% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/770866API
curl https://kongchang.com/api/v1/knowledge/claims/770866MCP
get_claim(id=770866)